Ascension Health Ventures, the $200m venture investment division of US medical company Ascension Health, has become the second corporate venturing unit to back Phreesia, a US-based provider of software for the doctor’s waiting room.

Ascension led the $16m series D round for Phreesia, along with the company’s previous investors. BlueCross BlueShield Venture Partners, a $116m corporate venture fund representing a national federation of 39 independent BlueCross BlueShield companies, led Phreesia’s $11.6m series C round in February…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?